2023. Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s151. DOI:https://doi.org/10.25251/skin.7.supp.151.